Brief Report

Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States

J Paul Leigh, Juan Du

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Few US estimates of the economic burden of autism spectrum disorders (ASD) are available and none provide estimates for 2015 and 2025. We forecast annual direct medical, direct non-medical, and productivity costs combined will be $268 billion (range $162–$367 billion; 0.884–2.009 % of GDP) for 2015 and $461 billion (range $276–$1011 billion; 0.982–3.600 % of GDP) for 2025. These 2015 figures are on a par with recent estimates for diabetes and attention deficit and hyperactivity disorder (ADHD) and exceed the costs of stroke and hypertension. If the prevalence of ASD continues to grow as it has in recent years, ASD costs will likely far exceed those of diabetes and ADHD by 2025.

Original languageEnglish (US)
Pages (from-to)4135-4139
Number of pages5
JournalJournal of Autism and Developmental Disorders
Volume45
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Autistic Disorder
Economics
Attention Deficit Disorder with Hyperactivity
Costs and Cost Analysis
Stroke
Hypertension
Autism Spectrum Disorder

Keywords

  • Costs
  • Non-medical services
  • Prevalence

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Cite this

Brief Report : Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States. / Leigh, J Paul; Du, Juan.

In: Journal of Autism and Developmental Disorders, Vol. 45, No. 12, 01.12.2015, p. 4135-4139.

Research output: Contribution to journalArticle

@article{14e6eb98df3245149a165ffc427410ea,
title = "Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States",
abstract = "Few US estimates of the economic burden of autism spectrum disorders (ASD) are available and none provide estimates for 2015 and 2025. We forecast annual direct medical, direct non-medical, and productivity costs combined will be $268 billion (range $162–$367 billion; 0.884–2.009 {\%} of GDP) for 2015 and $461 billion (range $276–$1011 billion; 0.982–3.600 {\%} of GDP) for 2025. These 2015 figures are on a par with recent estimates for diabetes and attention deficit and hyperactivity disorder (ADHD) and exceed the costs of stroke and hypertension. If the prevalence of ASD continues to grow as it has in recent years, ASD costs will likely far exceed those of diabetes and ADHD by 2025.",
keywords = "Costs, Non-medical services, Prevalence",
author = "Leigh, {J Paul} and Juan Du",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s10803-015-2521-7",
language = "English (US)",
volume = "45",
pages = "4135--4139",
journal = "Journal of Autism and Developmental Disorders",
issn = "0162-3257",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Brief Report

T2 - Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States

AU - Leigh, J Paul

AU - Du, Juan

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Few US estimates of the economic burden of autism spectrum disorders (ASD) are available and none provide estimates for 2015 and 2025. We forecast annual direct medical, direct non-medical, and productivity costs combined will be $268 billion (range $162–$367 billion; 0.884–2.009 % of GDP) for 2015 and $461 billion (range $276–$1011 billion; 0.982–3.600 % of GDP) for 2025. These 2015 figures are on a par with recent estimates for diabetes and attention deficit and hyperactivity disorder (ADHD) and exceed the costs of stroke and hypertension. If the prevalence of ASD continues to grow as it has in recent years, ASD costs will likely far exceed those of diabetes and ADHD by 2025.

AB - Few US estimates of the economic burden of autism spectrum disorders (ASD) are available and none provide estimates for 2015 and 2025. We forecast annual direct medical, direct non-medical, and productivity costs combined will be $268 billion (range $162–$367 billion; 0.884–2.009 % of GDP) for 2015 and $461 billion (range $276–$1011 billion; 0.982–3.600 % of GDP) for 2025. These 2015 figures are on a par with recent estimates for diabetes and attention deficit and hyperactivity disorder (ADHD) and exceed the costs of stroke and hypertension. If the prevalence of ASD continues to grow as it has in recent years, ASD costs will likely far exceed those of diabetes and ADHD by 2025.

KW - Costs

KW - Non-medical services

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=84947866144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947866144&partnerID=8YFLogxK

U2 - 10.1007/s10803-015-2521-7

DO - 10.1007/s10803-015-2521-7

M3 - Article

VL - 45

SP - 4135

EP - 4139

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

SN - 0162-3257

IS - 12

ER -